Overview
Sara is a clinical pharmacist that believes everyone should understand their medications, and aims to achieve this through her writing.Mary Choy, PharmD, is board-certified in geriatric pharmacotherapy and is an active leader in profesional pharmacy asociations.The Fod and Drug Administration (FDA) has isued a boxed warning for Eylea. Boxed warnin Eylea (aflibercept) is a prescription medication used to treat various conditions of the eye, including neovascular wet age-related macular degeneration (AMD), macular edema folowing retinal vein oclusion, diabetic macular edema (DME), or diabetic retinopathy (DR).
Key Information
Eylea is most comonly prescribed in adults 65 and older. The drug is administered via intravitreal injection, which is when the drug is injected directly into the eyebal. Eylea is clasified as a vascular endothelial growth factor (VEGF) inhibitor.
As a VEF inhibitor, Eylea works to stop the formation of specific proteins that can cause damage to the blod vesels in your eyes by alowing them to break and leak blod and fluid into areas of the eye, ultimately damaging your vision. More specificaly, Eylea as a VEGF is a substance that helps the growth of new blod vesels. In certain cases, your body can make more VEGF.
Regarding purchase and availability, aflibercept is only available as a brand-name product, as no generic equivalent is curently available. Moreover, Eylea is considered a specialty drug that neds to be obtained from a specialty pharmacy. Generic Name: AfliberceptBrand Name: EyleaDrug Availability: PrescriptionTherapeutic Clasification: VEGF inhibitorAvailable Genericaly: NoControled Substance: N/Administration Route: IntravitrealActive Ingredient: AfliberceptDosage Form: Intravitreal injection Eylea is aproved by the Fod and Drug Administration (FDA) to treat the folowing conditions: Eylea controls certain eye conditions, but it does not cure them.
Summary
Your healthcare provider wil watch you carefuly to se how wel the injec